Table 1.
Recommended Monitoring and Adherence Rate Results.
| Recommended Monitoring | Recommended Timing | Adherence Rate | ||
|---|---|---|---|---|
| Before Treatment | During Treatment | Before Treatment | During Treatment | |
| Thyroid function test | Once | Every 6 months | 97% | 59% full, 32% partial |
| Liver function test | 97% | 96% | ||
| Chest X-ray | Annually | 84% | 10% | |
| Respiratory function test | According to clinical manifestation | 2% | 21% (6/29 symptomatic patients) | |
| Ophthalmic evaluation | 64% | N/A | ||
| Neurologic evaluation | 0% | |||
| Dermatologic evaluation | 0% | |||
| Cardiac evaluation + ECG | Annually | 100% | 55% full, 45% partial | |
Abbreviations: ECG, electrocardiogram; N/A, not applicable.